NovoCure Total Liabilities 2014-2023 | NVCR
NovoCure total liabilities from 2014 to 2023. Total liabilities can be defined as the total value of all possible claims against the corporation.
| NovoCure Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2023 | $784 |
| 2022 | $750 |
| 2021 | $729 |
| 2020 | $575 |
| 2019 | $262 |
| 2018 | $228 |
| 2017 | $152 |
| 2016 | $140 |
| 2015 | $57 |
| 2014 | $20 |
| 2013 | $17 |
| NovoCure Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2023-12-31 | $784 |
| 2023-09-30 | $753 |
| 2023-06-30 | $743 |
| 2023-03-31 | $742 |
| 2022-12-31 | $750 |
| 2022-09-30 | $729 |
| 2022-06-30 | $721 |
| 2022-03-31 | $714 |
| 2021-12-31 | $729 |
| 2021-09-30 | $707 |
| 2021-06-30 | $700 |
| 2021-03-31 | $695 |
| 2020-12-31 | $575 |
| 2020-09-30 | $124 |
| 2020-06-30 | $261 |
| 2020-03-31 | $261 |
| 2019-12-31 | $262 |
| 2019-09-30 | $253 |
| 2019-06-30 | $247 |
| 2019-03-31 | $244 |
| 2018-12-31 | $228 |
| 2018-09-30 | $201 |
| 2018-06-30 | $198 |
| 2018-03-31 | $197 |
| 2017-12-31 | $152 |
| 2017-09-30 | $146 |
| 2017-06-30 | $139 |
| 2017-03-31 | $136 |
| 2016-12-31 | $140 |
| 2016-09-30 | $133 |
| 2016-06-30 | $64 |
| 2016-03-31 | $59 |
| 2015-12-31 | $57 |
| 2015-09-30 | $53 |
| 2015-03-31 | $0 |
| 2014-12-31 | |
| 2014-09-30 | $0 |
| 2013-12-31 | $17 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.527B | $0.509B |
| NovoCure Limited is an oncology company. The Company is engaged in developing a therapy called Tumor Treating Fields for the treatment of solid tumor cancers. It operates primarily in the United States, Germany, Switzerland and Japan. NovoCure Limited is based in Saint Helier, Channel Islands. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $122.161B | 15.33 |
| Cencora (COR) | United States | $44.832B | 17.48 |
| DiDi Global (DIDIY) | China | $24.983B | 0.00 |
| ICON (ICLR) | Ireland | $24.837B | 23.45 |
| Avantor (AVTR) | United States | $16.520B | 24.32 |
| Viatris (VTRS) | United States | $13.812B | 3.97 |
| CochLear (CHEOY) | Australia | $13.622B | 0.00 |
| Revvity (RVTY) | United States | $12.486B | 21.88 |
| Medpace Holdings (MEDP) | United States | $12.117B | 39.86 |
| Charles River Laboratories (CRL) | United States | $11.842B | 21.59 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.592B | 0.00 |
| Natera (NTRA) | United States | $11.317B | 0.00 |
| Solventum (SOLV) | United States | $11.238B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.201B | 0.00 |
| HealthEquity (HQY) | United States | $6.843B | 51.12 |
| Organon (OGN) | United States | $5.015B | 4.76 |
| Bausch + Lomb (BLCO) | Canada | $4.870B | 19.52 |
| Doximity (DOCS) | United States | $4.537B | 33.78 |
| PACS (PACS) | United States | $3.752B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.178B | 29.41 |
| Sotera Health (SHC) | United States | $3.088B | 15.15 |
| Progyny (PGNY) | United States | $3.082B | 51.73 |
| Life Times (LTH) | United States | $2.779B | 29.44 |
| GoodRx Holdings (GDRX) | United States | $2.769B | 140.20 |
| Premier (PINC) | United States | $2.543B | 9.31 |
| AMN Healthcare Services Inc (AMN) | United States | $2.281B | 7.38 |
| Teladoc Health (TDOC) | United States | $2.203B | 0.00 |
| Agilon Health (AGL) | United States | $1.985B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.893B | 0.00 |
| Agiliti (AGTI) | United States | $1.369B | 22.36 |
| Establishment Labs Holdings (ESTA) | $1.359B | 0.00 | |
| Alignment Healthcare (ALHC) | United States | $1.003B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.766B | 7.93 |
| Embecta (EMBC) | United States | $0.589B | 3.89 |
| InnovAge Holding (INNV) | United States | $0.554B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.511B | 0.00 |
| LifeMD (LFMD) | United States | $0.511B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.508B | 0.00 |
| Enhabit (EHAB) | United States | $0.501B | 45.41 |
| Auna S.A (AUNA) | Luxembourg | $0.500B | 0.00 |
| CareDx (CDNA) | United States | $0.480B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.466B | 0.00 |
| MultiPlan (MPLN) | United States | $0.429B | 0.00 |
| Beauty Health (SKIN) | United States | $0.399B | 0.00 |
| DocGo (DCGO) | United States | $0.366B | 58.50 |
| Sera Prognostics (SERA) | United States | $0.345B | 0.00 |
| ModivCare (MODV) | United States | $0.312B | 5.85 |
| Sharecare (SHCR) | United States | $0.269B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.265B | 0.00 |
| Biodesix (BDSX) | United States | $0.150B | 0.00 |
| So-Young (SY) | China | $0.128B | 43.00 |
| Oncology Institute (TOI) | United States | $0.086B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.072B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
| NeueHealth (NEUE) | United States | $0.050B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.038B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.037B | 0.00 |
| Nutex Health (NUTX) | United States | $0.032B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
| OncoCyte (OCX) | United States | $0.023B | 0.00 |
| DermTech (DMTK) | United States | $0.022B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.014B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| Assure Holdings (IONM) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |